PCSK9 inhibitors prior authorization: Redundant process due for a redesign
Document Type
Editorial
Department
Office of the Provost; Cardiology
Publication (Name of Journal)
Circulation: Cardiovascular Quality and Outcomes
DOI
10.1161/CIRCOUTCOMES.119.005910
Recommended Citation
Nasir, K.,
Angraal, S.,
Virani, S. S.
(2019). PCSK9 inhibitors prior authorization: Redundant process due for a redesign. Circulation: Cardiovascular Quality and Outcomes, 12(8), e00591.
Available at:
https://ecommons.aku.edu/provost_office/640
COinS
Comments
Pagination is not provided by the author/publisher. This work was published before the author joined Aga Khan University.